- €72.93m
- €70.77m
- €10.97m
Brief: Nexstim Gets NBS 5 System Order From German Hospital
Brief: Nexstim Receives Order For NBS System 5 From Boston VA Hospital
Brief: Nexstim Gets Order From U.S. Customer
Brief: Nexstim Gets NBS System Order From Finnish Hospital
Brief: Nexstim H2 Operating Loss Widens To EUR 1.5 Million
Brief: Nexstim Oyj Approved Delisting Application Regarding Secondary Listing On Nasdaq First North Growth Market Sweden
Brief: Nexstim Receives NBS System Order From Hong Kong
Brief: Nexstim Gets NBT System Order From Finnish Hospital
Brief: Nexstim Receives Order For Two NBT Systems
Brief: Nexstim Receives NBS System Order From Hospital In Poland
Brief: Nexstim Receives Order From Alamo Neurosurgical Institute
Brief: Nexstim Reports Treatment Outcomes Of Over 400 MDD Patients
Brief: Nexstim H1 Operating Result Turns To Profit Of EUR 2.3 Mln
Brief: Nexstim Gets NBS System Order From Finnish Customer
Brief: Nexstim Receives Order From Seattle Children’S Hospital
Brief: Nexstim Receives Order For Two NBS Systems From Finnish University Hospital
Brief: Nexstim Agrees On Minority Interest
Brief: Nexstim Receives NBS 5+ System Order In US
Brief: Nexstim H2 Operating Loss Narrows To EUR 0.5 Mln